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Development of 19F NMR for Measurement of
[Ca2+]a and [Pb2+]1 in Cultured Osteoblastic
Bone Cells
by Francis A. X. Schanne*t, Terry L. Dowd,* Raj K. Gupta,*
and John F. Rosen*
Lead (Pb) has been shown to perturb cellular calcium (Ca) homeostasis, altering sizes and flux
rates of cellular pools of exchangeable Ca and impairing Ca-mediated cell processes. To date,
however, a direct effect of Pb on intracellular-free Ca2+ has not yet been demonstrated. Heavy
metals bind to the commonly used fluorescent Ca ion indicators with greater afflnity than does Ca
and thereby interfere with the expected Ca-dependent fluorescence.
In this study, the fluorinated Ca ion indicator, 1,2-bis(2-amino-5-fluorophenoxy)ethane
N,N,N',N'-tetraacetic acid (5F-BAPTA), and "F NMR were used to measure the free intracellular
Ca ion concentration ([Ca2`],) in the rat osteoblastic bone cell line, ROS 17/2.8. Both Pb and Ca
bind to 5F-BAPTA with high affinity, but the Pb-5F-BAPTA comple produces a "9F NMR signal at a
chemical shift distinct from 5F-BAPTA and the Ca-5F-BAPTA complex. The apparent dissociation
constants for Pb-5F-BAPTA and Ca-5F-BAPTA are 2 x 10-10 M and 5 x 10-7 M, respectively, at 30'C,
pH 7.1, and Mg2+ (0.5 mM). Thus, this methodology allows for the simultaneous identification and
quantification of free Pb and free Ca ion concentrations. Determinations of[Ca2+1J were based on
"9F NMR measurements of5F-BAPTA-loaded ROS 17/2.8 osteoblastic bone cells that were attached
to collagen-coated mictocarrier beads. Cells were continuously superfused with freshly oxygen-
ated medium at 30'C. Under these conditions, the [Ca2+J1 of ROS 17/2.8 cells was observed to be
128 ± 14 nM. Treatment with parathyroid hormone produced a nearly 2-fold increase in [Ca2+J
within the first half hour, with a subsequent return to pretreatment levels. This work demon-
strates the usefubness of 5F-BAPTA and "9F NMR for measuring [Ca2+], in cells in monolayer
culture in response to physiologic agents, and it indicates its potential for studies of the toxic
effect of heavy metals on cellular Ca homeostasis.
Introduction
In 1985, the Centers for Disease Control lowered its
definition of an elevated blood lead level from 30 to 25
gg/dL in young children (1). Current estimates with
this standard have indicated that 1.5 to 2.3 million
American children have elevated blood lead values
(2,3), values associated with multiple metabolic (4),
neurologic (5,6), and behavioral disorders (6,7). Evi-
dence also continues to accumulate that demonstrates
associations between even lower blood lead levels and
reductions in mental development (8), decreased skel-
etal growth (9) and disturbances in cardiovascular
function (10,11). One such epidemiologic study, which
analyzed data from the Second National Health and
Departments of *Pediatrics, tPathology, and tPhysiology and
Biophysics, Albert Einstein College of Medicine, Montefiore Medi-
cal Center, Bronx, NY 10467.
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Nutrition Examination Survey, revealed a strong neg-
ative correlation between blood lead levels and height
or skeletal growth in children (9).
Interactions between Pb toxicity and Ca metabo-
lism are well recognized, both at the level of the
organism as a whole and at the cellular level (12). The
handling of Ca and Pb by bone cells is given special
importance because bone is the major reservoir in the
body for both the essential metal Ca and the toxic
metal Pb. A comprehensive basis on which to access
the possible sites where Pb might interfere with Ca
homeostasis at the cellular level can be derived from
45Ca desaturation kinetic techniques. Pounds and
Rosen, using this methodology, described the steady-
state homeostasis of Ca in primary cultures of murine
osteoclastic bone cells as consisting of three distinct
intracellular compartments of exchangeable Ca (13).
They found that adding increasing concentrations of
Pb to the extracellular medium resulted in elevations
in all three intracellular compartments. The largestSCHANNE ETAL.
increase occurred in the most slowly exchanging com-
partment that includes the mitochondrial calcium.
In virtually every tissue where the effects of lead
were studied in detail, the results suggested that lead
alters calcium homeostasis and calcium-mediated cell
function. In nerve (14,15), smooth muscle (16), cardiac
muscle (17), liver (16,19), and bone cells (13,20), the
hypothesis has been proposed that lead causes an
increase in intracellular pools of calcium and a
decrease in the ability of cells to extrude calcium or
lower the effective free intracellular calcium ion con-
centrations [Ca2+]i.
The appropriate temporal and spatial availability
of intracellular Ca is critical to the modulation of
cellular structure, function, and activity. Given the
central role of[Ca2+]i in the regulation of cellular pro-
cesses, we propose that an early, discrete, yet common
event in the mechanism of low-level lead toxicity is
the inappropriate elevation and regulation of [Ca2+]i,
leading to an important subset of the variety and
magnitude of disorders associated with lead toxicity.
In order to directly test this hypothesis, [Ca2]i
must be measured in a target tissue of Pb effects; and
[Ca2+]i dynamics must also be measured in response to
normal physiologic calciotropic agents and to Pb
treatment. Testing this hypothesis requires a meth-
odology that can measure [Ca2+]i in the presence of
Pb. The commonly used fluorescent Ca indicators
Quin-2, Fura-2 and Indo-1 bind heavy metals with
greater specificity than they do Ca (21,22). It has thus
far proven difficult, if not impossible, to dissociate
fluorescence changes that reflect actual changes in
[Ca2+]i from those reflecting the binding ofheavy met-
als (22,23), without specifically removing the heavy
metals from the cells being studied (22). Pb has also
been shown to trigger luminescence of the
photoprotein Ca indicator, aequorin (24,25), thereby
eliminating it as an alternative [Ca2+]i indicator in
these studies.
While the high-affinity binding of heavy metals is a
major drawback for the fluorescent and biolumines-
cent indicators, it represents a major advantage for
the 5,5'difluoro derivative of 1,2-bis(2-aminophe-
noxy)ethane-N,N,N',N'-tetraacetic acid (5F-BAPTA)
(26). BAPTA, the predecessor of Quin-2 and Fura-2,
symmetrically substituted with fluorine at the 5 posi-
tion of the two rings, is a cation indicator that can be
monitored by '9F nuclear magnetic resonance spec-
troscopy (19F NMR). The '9F chemical shift of this
compound is highly sensitive to chelation with metal
ions (Mn+). These '9F chemical shifts are characteris-
tic and distinct for 5F-BAPTA and each Mn+-5F-
BAPTA complex thus far described (26). Further-
more, the areas of the resonances from the bound
(Mn+-5F-BAPTA) and free (5F-BAPTA) forms of the
indicator are proportional to their concentrations,
and the free M" concentration can be calculated by
knowing the dissociation constant for Mn+-5F-
BAPTA. Thus, '9F NMR permits the identification
and quantitation of each chelated ion. Metcalfe and
co-workers have successfully employed this methodol-
ogy to simultaneously monitor changes in [Ca2+]i and
intracellular [Zn2+] (27).
In testing our hypothesis, it is appropriate to
choose a cell that is a target of low-level Pb toxicity.
Osteocalcin, the vitamin K-dependent protein found
in bone matrix, is a specific biochemical marker of
osteoblastic activity and can be measured in the
serum. Markowitz, Gundberg and Rosen (28) observed
that in lead-toxic children, those with the highest
body burden of Pb had the lowest osteocalcin levels.
Successful reduction of body Pb stores by
CaNa2EDTA chelation therapy ultimately resulted in
marked elevations in circulating osteocalcin levels.
Although regulation of osteoblastic activity is mul-
tifactorial, these data suggest that Pb either directly
or indirectly impairs osteoblastic activity. Such toxic
effects on osteoblastic function could also explain the
observed negative correlation between skeletal
growth and blood Pb values in children (9).
For our experiments, we have chosen the rat osteo-
blastic osteosarcoma cell line, ROS 17/2.8. The ROS
17/2.8 cell is well characterized, highly differentiated,
and phenotypically an osteoblast (29). These cells syn-
thesize osteocalcin, have high alkaline phosphatase
activity, possess 1,25-dihydroxyvitamin D3 receptors,
and respond to parathyroid hormone (PTH) by
increasing adenylate cyclase activity (29) and elevat-
ing [Ca2+]i (30). The responsiveness of these cells to
PTH allows us to assess the usefulness of our [Ca2]i
indicator in monitoring the normal response of these
cells to a physiologic calciotropic hormone.
Methods
Cell Culture
ROS 17/2.8 cells were maintained and grown to
confluence in 75-cm2 flasks with Ham's F-12 nutrient
mixture supplemented with 5% fetal bovine serum
and 28 mM HEPES buffer, pH 7.4 (F-12 medium).
Two days before NMR observations were made, the
ROS 17/2.8 cells were harvested by trypsinization
(0.01% in Ca2+-Mg2+-free Hank's balanced salt solu-
tion) and attached to collagen-coated microcarriers
(Cytodex 3, Pharmacia), which had been swollen in
saline and equilibrated in F-12 medium. One hundred
twenty million cells were seeded onto 8 mL of swollen
beads (approximately 0.6 g dry wt). Upon attachment
and flattening, complete confluence was achieved
within 24 hr. ROS 17/2.8 cells on beads were main-
tained in 500 mL of F-12 medium in a 1-L siliconized
glass, Techne stir vessel at 35 rpm, 370C, 95% air, 5%
C02, humidified atmosphere. The medium was
changed twice daily.
Loading with 5F-BAPTA
Cells were loaded with 5F-BAPTA in the stirring
culture flask for 45 min. This was done by adding the
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acetoxymethyl ester of 5F-BAPTA at a concentration
of 20 gm from a 50-mM stock solution in dimethyl-
sulfoxide. The loading medium was removed, the cells
were washed in fresh F-12 medium and were allowed
1 hr to recover from loading. Next, cells on beads were
transferred to a 10-mm diameter NMR tube. An
inflow tubing line was inserted down through the
beads to the bottom of the NMR tube, and an outflow
tubing line was inserted to the top of the NMR tube.
The NMR tube was sealed with a rubber stopper and
the F-12 medium, saturated with 95% 02, 5% Co2,
was superfused through the NMR tube at a rate of 2
mL/min, discarding the effluent. The NMR samples
were maintained at 30°C throughout the signal
accumulation (Fig. 1).
NMR
NMR measurements of 5F-BAPTA-loaded cells
were performed on a Varian 500 MHz spectrometer
using a 10-mm broad band probe. The decoupler coil,
used to observe the 19F resonance, was tuned to
470.268 MHz. NMR parameters were as follows: acqui-
sition time, 0.8 sec; pulse angle, 90°; and spectral
width, 10 KHz. Each spectrum represented the
Fourier transformation of the sum of 2500 free induc-
tion decays (FID) over a time interval of 33.3 min
Each experiment was begun by acquiring three con-
secutive spectra in order to establish baseline [Ca2]i
in untreated cells. Treatments were initiated by addi-
tion to the superfusion medium. NMR measurements
of standard aqueous solutions, performed to deter-
mine MnI-5F-BAPTA chemical shifts and apparent
binding constants, were also performed on the Varian
500 MHz spectrometer; but a 5-mm diameter tube and
a dedicated fluorine probe were used.
31p NMR spectra of ROS 17/2.8 cells were also
obtained on the Varian 500 MHz spectrometer opera-
ting at 202.3 MHz for phosphorous-31. The NMR
parameters were: acquisition time, 0.8 sec; pulse
angle, 900; spectral width, 20 KHz, and a recycle time
of 1.6 sec. Each spectrum represented the Fourier
transformation of the sum of 8,000 transients, using a
line-broadening function of 50 Hz. The intracellular
WASTE
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FIGURE 1. Schematic of superfusion system for maintaining ROS
17/2.8 cells attached to Cytodex #3 microcarrier beads while in
the NMR spectrometer.
pH of the cells was determined based on the chemical
shift difference between the intracellular inorganic
phosphate (Pi) and phosphocreatine (PCR) peaks as
previously described (31), and was found to be 7.1. The
intracellular-free Mg2+ concentration was determined
based on the chemical shift difference between the Pa
andPp peaks of ATP (32), and was found to be 0.5 mM.
The intracellular volume was estimated based on phe-
notypic morphology (29).
Apparent Dissociation Constants
The Kd for Ca-5F-BAPTA was determined under
the following conditions: KCI (135 mM), MgCl2 (0.5
mM), K4-5F-BAPTA (0.385 mM), MOPS buffer (10
mM), pH 7.1, 30°C and varying amounts of CaCl2.
Free Ca2+ concentrations were measured by using a
Ca2+-selective ion electrode (Orion) that was cali-
brated with Ca-EDTA standards. The intensities of
Ca-5F-BAPTA and 5F-BAPTA resonances, which are
proportional to their concentrations, were measured
using the areas under their respective '9F peaks. The
electrode-determined free Ca21 concentration was
plotted verses the ratio of the bound-to-free 5F-
BAPTA, yielding the Kd as the slope. The Kd for Pb-
5F-BAPTA was determined by competition with Ca2+.
Materials
ROS 17/2.8 cells were a generous gift from Dr. G. A.
Rodan (Merck Sharp and Dohme, West Point, PA).
5F-BAPTA and its acetoxymethyl ester (AME) were
synthesized by Dr. Iraj Lalezari by previously
described methods (33). Synthetic bovine PTH (1-34)
was obtained from Sigma (St. Louis, Mo). Collagen-
coated microcarriers (Cytodex 3) were obtained from
Pharmacia (Uppsala, Sweden).
Results and Discussion
The purpose of this report is to describe and deter-
mine the potential usefulness of 5F-BAPTA and 19F
NMR as a methodology for measuring [Ca2+]i in a
single population of cells in monolayer culture during
treatment with Pb. Several criteria must be met in
order to demonstrate the usefulness ofthis technique.
First, the technique must be able to distinguish and
measure [Ca2+]i in the presence of Pb. The indicator
5F-BAPTA must be taken up and trapped within the
cells in sufficient quantity to yield a clearly observa-
ble 19F NMR signal. This must be achieved without
producing permanent alterations in cellular energet-
ics and ion balances. Moreover, the methodology must
prove effective in monitoring normal changes in
[Ca2+]j, such as those produced by physiologic, calcio-
tropic hormones.
Figure 2 represents the "9F NMR spectrum of a
solution that contained K45F-BAPTA (0.52 mM),
MgC12 (0.5 mM), ZnSO4 (0.13 mM), Pb (C2H302)2 (0.13
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FIGURE 2. 19F NMR spectrum of 5F-BAPTA (0.52 mM) in aqueous solution with MgCl2 (0.5 mM), ZnSO4 (0.13 mM), Pb(C2H302)2 (0.13 mM),
CaCl2 (0.13 mM), KCl (135 mM), MOPS (10 mM), pH 7.1. at 30°C and 470.268 MHz. The resonance peaks are as indicated for free 5F-
BAPTA (K+, Mg2+) and each Mn+-5F-BAPTA complex (Ca2', Pb2+, Zn2+). Inset represents the structure of 5F-BAPTA.
mM), CaCl2 (0.13 mM), KCl (135 mM), and MOPS (10
mM) with a pH 7.1 at 30°C. This spectrum illustrated
the relative 19F chemical shifts for 5F-BAPTA and its
complexes with Zn and Ca that are consistent with
those originally described by Smith et al. (24). Fur-
thermore, this spectrum clearly demonstrated a dis-
tinct chemical shift for Pb-5F-BAPTA. This Pb-5F-
BAPTA peak fell between the peaks of Ca and Zn
bound complexes, 0.8 ppm upfield from the Ca-5F-
BAPTA resonance. The free 5F-BAPTA was in rapid
exchange with Mg2' complex so that the latter does
not give rise to a distinct resonance, rather it merely
results in a broadening of the free 5F-BAPTA
resonance (24). With the Kd for Mg-5F-BAPTA in the
range of 17 mM (24,33), the amount offree 5F-BAPTA
bound to Mg2' at 0.5 mM was approximately 3%. In
order to fully compensate for the slight association of
Mg2+ with the 5F-BAPTA, all apparent binding con-
stants were determined in the presence of 0.5 mM
MgCl2, the [Mg2+]i of ROS 17/2.8 cells, as determined
by 31P NMR.
Determination of the Kd for Ca-5F-BAPTA under
these conditions was based on the free [Ca2+]i versus
the ratio of the Ca2' bound to free forms of the che-
lator measured by 19F NMR. The Kd for Ca-5F-
BAPTA was 5.0 ± 0.2 x 10' M (mean ± SEM, n = 8).
This value is similar to those reported by Smith et al.
(26) and Levy et al. (34), especially accounting for
differences in temperature and Mg concentration, but
nearly twice that reported by Marban et al. (35).
Determination of the Kd for Pb-5F-BAPTA was
based on competition between Pb and Ca for binding
to 5F-BAPTA and was measured by 19F NMR. This
yielded a Kd of 2.1 ± 0.5 x1010 M (mean ± SEM, n =
4) for Pb-5F-BAPTA. The determination of the spe-
cific, characteristic chemical shifts for both Ca-5F-
BAPTA and Pb-5F-BAPTA, as well as their apparent
Kds, would thereby permit the simultaneous identifi-
cation and measurement of both [Ca2'] and [Pb2+] by
this technique.
Figure 3 represents a typical 19F NMR spectrum
from control, untreated ROS 17/2.8 cells on microcar-
rier beads. The cells were loaded with 5F-BAPTA.
ROS 17/2.8 cells were superfused with medium at 2
mL/min at 30°C in an NMR tube for an additional
hour to achieve equilibrium. The free 5F-BAPTA
peak was set at 0 ppm with the resonance of Ca-5F-
BAPTA complex located 5.7 ppm downfield. These
were consistent with their identification in Figure 2.
Figure 3 illustrates two clearly distinct, definable,
and measurable 19F resonance signals from which the
ratio of free-to-bound forms of 5F-BAPTA was deter-
mined. This ratio, together with the measured Kd,
yielded [Ca2+]i of untreated ROS 17/2.8 cells of 128 ±
14 nM (mean ± SD, n = 10).
The total 5F-BAPTA trapped within cells was
approximately 0.5 mM. This determination was based
on the total 19F signal measured during the initial
FID accumulation interval, compared to 5F-BAPTA
concentration standards. The total 19F signal was
measured at each 33.3 min accumulation interval
throughout the course of all experiments, each of
which lasted 5 to 7 hr. Based on the 19F signal mea-
sured at each interval, there was an apparent first-
order rate of loss of 5F-BAPTA of 12%/hr. It must be
noted that these cells were being superfused with
medium at a rate of 2 mL/min. Thus, any 5F-BAPTA
that leaked from the cells was constantly being
diluted and washed away, thereby contributing less
than 0.5% to the '9F signal in any given accumulation
interval. Despite this constant loss of intracellular
indicator, there were no concurrent changes in the
[Ca2+]i measured in the cells during the time course of
the NMR experiments. Therefore, while 5F-BAPTA
may act as a major intracellular Ca2" buffer, its con-
centration did not alter the steady state [Ca21]i, which
was consistent with the findings of Murphy et al. in
red blood cells (36).
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FIGURE 3. 19F NMR spectrum of ROS 17/2.8 cells on microcarrier beads which had been loaded with 5F-BAPTA and allowed to equilibriate.
Superfusion was carried out at 30 °C with F-12 medium (2 mL/min) in a 10-mm diameter NMR tube. The free 5F-BAPTA and the Ca-
5F-BAPTA complex (Ca2+) are identified.
In order to assess the viability, metabolic integrity,
and ion balance of ROS 17/2.8 cells following their
loading with 5F-BAPTA, a 31P spectrum was
obtained. Figure 4 represents the 31P spectrum of ROS
17/2.8 cells loaded with 5F-BAPTA. The large
resonance toward the left end of the spectrum repre-
sented the extracellular inorganic phosphate (Pi),
which was 1 mM in the medium. The phosphocreatine
(PCR) and the Pa,,, Pp, and PR resonance peaks of ATP
were also identified. 31P spectra were obtained to
quantitate several critical indicators of cellular func-
tioning: a) the size of the Pp resonance of ATP is
proportional to the cellular ATP concentration (37);
b) the intracellular pH was determined based on the
chemical shift difference between the intracellular Pi
and PCR peaks (31); and c) the [Mg2+]i was determined
ATP
10 5 0 -5 -10 -15 -20 -25 -30
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FIGURE 4. 31P NMR spectrum of ROS 17/2.8 cells treated as in Figure 3. The large resonance toward the left of the spectrum represents
extracellular inorganic phosphate. Phosphocreatine (PCR) and the Pa, Pp, and Pr resonance peaks of ATP are identified.
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based on the chemical shift difference between the P,
and Pi resonance peaks of ATP (32).
Under our conditions of loading, recovery and
superfusion, there was virtually no observable differ-
ence in the 31P NMR spectrum of ROS 17/2.8 cells,
which had been loaded with 5F-BAPTA, compared to
those which had not been loaded with respect to ATP
level, intracellular pH, and [Mg2+]i. These findings
indicated that 5F-BAPTA loading appeared to have
left ROS 17/2.8 cells intact in terms of viability, met-
abolic integrity, and ionic balance.
Finally, this technique was used to study the
response of ROS 17/2.8 cells to hormonal stimulation.
Figure 5 shows '9F spectra, which demonstrate the
response of ROS 17/2.8 cells to treatment with PTH
(400 ng/mL). Panel A represents untreated ROS 17/
2.8 cells, as seen in Figure 3, but immediately before
addition of PTH. The [Ca2+]i was 130 nM. Panel B
represents the 19F spectrum accumulated during the
first 33 min after addition of PTH. [Ca2+]i had risen to
240 nM. Panel C represents the '9F signal during
Free
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FIGURE 5. 9F NMR spectra of 5F-BAPTA loaded ROS 17/2.8 cells
before (A), during (B), and after (C) treatment with PTH (400
ng/mL). Panel A represents '9F signal accumulation interval
immediately before treatment with PTH. Panel B represents
19F signal accumulation after addition of PTH. Panel C repre-
sents 19F signal accumulation during washout of PTH following
100 min of treatment. Each '9F signal accumulation interval
required 33.3 min.
washout of PTH, which followed 100 min of treat-
ment. During this time period, the [Ca2+]i had fallen to
140 nM or near pretreatment levels. These spectra
illustrated changes in the size of the Ca-5F-BAPTA
19F resonance, as compared to the free 5F-BAPTA in
response to PTH treatment. The full time course of
changes in [Ca2+]i in response to PTH, as monitored by
19F NMR, is illustrated in Figure 6. These data showed
the responsiveness of ROS 17/2.8 cells to hormonal
stimulation, as evidenced by an anticipated rise in
[Ca2+]j, which is consistent with the findings of
Yamaguchi et al. (30).
Conclusions
This report describes the usefulness of 5F-BAPTA
and 19F NMR as a methodology for measuring [Ca21]i
in ROS 17/2.8 osteoblastic bone cells in monolayer
culture. The cells were grown to confluence and main-
tained on collagen-coated microcarriers and were
subsequently loaded with 5F-BAPTA to yield clearly
observable 19F NMR spectra, which were used to
determine the [Ca21]i. Loading with 5F-BAPTA
occurred without producing irreversible alterations in
cellular functioning, demonstrated by ATP levels,
intracellular pH, [Mg21], and hormonal responsive-
ness to PTH. 5F-BAPTA and 19F NMR have proven
effective in measuring changes in [Ca21]i in response
to this calciotropic hormone.
The time intervals required to accumulate suffi-
cient signal intensity for accurate measurements of
[Ca21]i were considerably longer than those for more
commonly used indicators such as Quin-2, Fura-2 and
aequorin. However, these results demonstrate the
advantage of using NMR for studying cells under
long-term stable conditions, such as our oxygenated
superfused monolayer cultures.
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FIGURE 6. Time course of change in [Ca2]i in ROS 17/2.8 cells in
response to PTH treatment.
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This technique provides for monitoring long-term
steady-state changes in [Ca2+]i that may occur in
response to hormonal stimulation or toxic insult.
These changes are distinct from the rapid changes
more readily measured using the fluorescent and
chemoluminescent Ca2' indicators. Furthermore, the
demonstration that 5F-BAPTA and 19F NMR can
selectively identify and measure concentrations of
both Ca2" and Pb2+ simultaneously indicates the
potential for these methods to be used in toxicological
studies of the effects of Pb and other heavy metals on
intracellular [Ca2+] homeostasis.
NOTE ADDED IN PROOF: Using this methodology, we
have recently described a Pb-induced sustained eleva-
tion in [Ca2+]i and detected [Pb2+]i in ROS 17/2.8 cells
(38).
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